Recordati Industria Chimica e Farmaceutica

Transaction in Own Shares • Jan 2, 2025

RECORDATI: UPDATE ON THE EXECUTION OF THE SHARE BUY-BACK PROGRAM

Milan, 2 nd January 2025 – Within the Recordati's share buy-back program communicated to the market on 11th November 2024 and initiated on 12 th November 2024, as per authorization granted by the Shareholders' Meeting held on 22nd April 2024, with the object of the servicing of current stock option / performance shares plans in favour of the Recordati Group's management or share-based incentive plans that might be approved by the Company in the future, the Company communicates the following purchase transactions of Recordati shares pursuant to art. 2, paragraph 3, of the EU Delegated Regulation 2016/1052/EU, on the basis of the information provided by UBS Europe SE as intermediary in charge of executing, in full independency, the share buy-back program on behalf of the Company.

Aggregate details of daily transactions made from 23rd to 27 th December 2024 in Recordati ordinary shares (ISIN IT0003828271) are as follows:

SUMMARY OF PURCHASE TRANSACTIONS
Date	Type of Transaction	Quantity	Weighted average price	Exchange
			(Euro)
23/12/2024	Purchase	4,788	50.2710	MTA
27/12/2024	Purchase	10,082	50.7340	MTA
TOTAL		14,870	50.5849

The details of all the purchase transactions carried out in the period indicated above are reported in the following pages.

On 27 th December 2024, the Company held no. 2,802,133 treasury shares which amount to 1.340% of the current share capital.

Recordati is an international pharmaceutical group listed on the Italian Stock Exchange (XMIL: REC), with roots dating back to a family-run pharmacy in Northern Italy in the 1920s. We are uniquely structured to provide treatments across specialty and primary care, and rare diseases. Our fully integrated operations span clinical development, chemical and finished product manufacturing, commercialization and licensing. We operate in approximately 150 countries across EMEA, the Americas and APAC with over 4,450 employees. We believe that health is a fundamental right, not a privilege. Today, our purpose of "unlocking the full potential of life" aims at empowering individuals to live life to the fullest, whether addressing common health challenges or the rarest.

Investor Relations

Eugenia Litz +44 7824 394 750 investorelations@recordati.it Gianluca Saletta +39 348 979 4876 investorelations@recordati.it

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.

Registered Office Via Matteo Civitali, 1 20148 Milano, Italy Tel. +39 02 487871 Fax +39 02 40073747 www.recordati.com

Share Capital € 26.140.644,50 fully paid-up Milano, Monza, Brianza and Lodi Comp. Reg. No. 00748210150 Tax Code/VAT No. 00748210150 Milano R.E.A. No. 401832

Company subject to the Management and Coordination Activity of Rossini Luxembourg S.àr.l

Media Relations

ICR Healthcare US: Alexis Feinberg +1 203 939 2225 recordatiuspr@westwicke.com UK, Europe & Rest of World: Jessica Hodgson +44 7561 424 788 recordati@consilium-comms.com

Attachment: daily details of transactions

Date	Time (GMT)	Currency	Exchange	Price	Quantity
23/12/2024	08:05:00	EUR	MTA	50,1500	566
23/12/2024	08:15:47	EUR	MTA	50,1000	143
23/12/2024	08:15:47	EUR	MTA	50,1000	155
23/12/2024	08:15:47	EUR	MTA	50,1000	122
23/12/2024	08:15:47	EUR	MTA	50,1000	125
23/12/2024	08:32:32	EUR	MTA	50,0500	14
23/12/2024	08:32:32	EUR	MTA	50,0500	170
23/12/2024	08:32:32	EUR	MTA	50,0500	125
23/12/2024	08:32:32	EUR	MTA	50,0500	265
23/12/2024	08:46:34	EUR	MTA	50,2500	125
23/12/2024	08:46:34	EUR	MTA	50,2500	265
23/12/2024	08:46:34	EUR	MTA	50,2500	50
23/12/2024	08:46:34	EUR	MTA	50,2500	79
23/12/2024	09:07:06	EUR	MTA	50,2500	539
23/12/2024	09:32:33	EUR	MTA	50,3500	182
23/12/2024	09:32:33	EUR	MTA	50,3500	226
23/12/2024	09:32:33	EUR	MTA	50,3500	61
23/12/2024	09:32:33	EUR	MTA	50,3500	81
23/12/2024	09:52:52	EUR	MTA	50,4000	587
23/12/2024	10:10:50	EUR	MTA	50,4500	618
23/12/2024	10:58:02	EUR	MTA	50,5500	60
23/12/2024	10:58:02	EUR	MTA	50,5500	230
27/12/2024	08:07:31	EUR	MTA	50,5000	575
27/12/2024	08:08:40	EUR	MTA	50,4500	602
27/12/2024	08:08:48	EUR	MTA	50,3500	642
27/12/2024	08:25:46	EUR	MTA	50,5500	98
27/12/2024	08:25:46	EUR	MTA	50,5500	148
27/12/2024	08:25:46	EUR	MTA	50,5500	355
27/12/2024	08:50:02	EUR	MTA	50,6500	135
27/12/2024	08:50:02	EUR	MTA	50,6500	135
27/12/2024	08:50:02	EUR	MTA	50,6500	249
27/12/2024	08:58:14	EUR	MTA	50,7000	532
27/12/2024	09:42:29	EUR	MTA	50,6500	553
27/12/2024	10:11:30	EUR	MTA	50,7500	552
27/12/2024	10:31:58	EUR	MTA	50,6000	16
27/12/2024	10:33:28	EUR	MTA	50,6000	25
27/12/2024	10:35:47	EUR	MTA	50,6000	555
27/12/2024	11:48:00	EUR	MTA	50,7000	571
27/12/2024	11:48:00	EUR	MTA	50,7000	3
27/12/2024	12:55:33	EUR	MTA	50,9500	452
27/12/2024	12:55:33	EUR	MTA	50,9500	74
27/12/2024	13:55:22	EUR	MTA	50,9000	135
27/12/2024	13:55:22	EUR	MTA	50,9000	492
27/12/2024	13:55:22	EUR	MTA	50,9000	621
27/12/2024	13:55:22	EUR	MTA	50,9000	18

27/12/2024	14:39:32	EUR	MTA	50,9500	566
27/12/2024	14:52:35	EUR	MTA	51,0000	583
27/12/2024	15:05:00	EUR	MTA	50,9000	518
27/12/2024	15:30:57	EUR	MTA	50,9000	301
27/12/2024	15:53:02	EUR	MTA	50,9500	290
27/12/2024	16:15:31	EUR	MTA	50,9500	96
27/12/2024	16:15:31	EUR	MTA	50,9500	190